AffirmedRx, a Public Benefit Corporation

The PBM market is shifting. And it’s not just talk anymore — it’s action. As outlined in this Fierce Healthcare article, 7-Eleven and Purdue University will move to AffirmedRx in 2025, joining a growing list of employers moving to more transparent PBM models. “In 2025 and 2026, we’re going to see the fast followers move. And in 2026 and 2027, I think we’re really going to see a lot of general uptick in full market adoption of these newer, more transparent PBM models.” – Greg Baker, CEO of AffirmedRx The shift is clear: ✅ Early adopters are moving. ✅ Fast followers are on deck. ✅ Full market adoption is coming. Are you prepared for this shift, or are you still waiting for the market to force your hand? https://lnkd.in/eXhFUV8a Noah Tong Antonio Ciaccia Jeffrey Townsend Alex Azar Danny S.

PBM reform is on the table in Congress and it’s a big deal for employers, employees and the entire health care industry. As part of the year-end federal spending bill, lawmakers are taking action to create a fairer, more transparent PBM system that will reduce drug costs and protect consumers. Here’s what’s coming: • 𝗘𝗹𝗶𝗺𝗶𝗻𝗮𝘁𝗲 𝗦𝗽𝗿𝗲𝗮𝗱 𝗣𝗿𝗶𝗰𝗶𝗻𝗴: Currently PBMs can charge health plans more for a drug than they pay pharmacies and keep the difference. The reform will end this practice and employers and patients won’t pay more than they should. • 𝗥𝗲𝗯𝗮𝘁𝗲 𝗣𝗮𝘀𝘀-𝗧𝗵𝗿𝗼𝘂𝗴𝗵𝘀: Ever wonder where those manufacturer rebates go? Spoiler: they don’t always go to the consumer. The new rules will require PBMs to pass rebates directly to plan sponsors, which will mean real savings for employers and employees. • 𝗗𝗲𝗰𝗼𝘂𝗽𝗹𝗲 𝗣𝗕𝗠 𝗖𝗼𝗺𝗽 𝗳𝗿𝗼𝗺 𝗗𝗿𝘂𝗴 𝗣𝗿𝗶𝗰𝗲𝘀: When PBM profits are tied to the list price of the drug, no wonder prices stay high. These reforms will separate PBM earnings from drug prices and remove the financial incentive to keep prices high. These changes have the potential to be a big win for employers dealing with rising health care costs and employees struggling to afford their medications. It’s also a big moment for transparent PBMs like AffirmedRx, whose model already aligns with these principles. 𝗪𝗵𝘆 𝘁𝗵𝗶𝘀 𝗺𝗮𝘁𝘁𝗲𝗿𝘀 𝗳𝗼𝗿 𝗲𝗺𝗽𝗹𝗼𝘆𝗲𝗿𝘀: With the fiduciary duty pressure on employers under the Consolidated Appropriations Act (CAA) it’s more important than ever to make sure PBM contracts are transparent, fair and compliant. Large employers are facing class action lawsuits and these reforms give them a chance to get ahead of the curve and protect employee benefits. At AffirmedRx we’ve been advocating for these very practices for years. Full rebate pass-through, transparent pricing and eliminating spread pricing aren’t just reform ideas – 𝘁𝗵𝗲𝘆’𝗿𝗲 𝗼𝘂𝗿 𝘄𝗮𝘆 𝗼𝗳 𝗱𝗼𝗶𝗻𝗴 𝗯𝘂𝘀𝗶𝗻𝗲𝘀𝘀. If you’re an employer wondering what this means for your benefits strategy now is the time to act. The status quo is changing and those who get ahead of it will be best positioned for success. Want to know how these reforms will impact your PBM strategy? We’re happy to chat. Drop a comment below or send us a message. https://lnkd.in/eetYUQqM

Already, large employers are starting to move from traditional PBMs to next-generation upstarts. Convenience store chain 7-Eleven and Purdue University will be moving to AffirmedRx in 2025. “We’re seeing the early adopters move,” Greg Baker, CEO of AffirmedRx told Fierce Healthcare. “In 2025 and 2026, we’re going to see the fast followers move. And in 2026 and 2027, I think we’re really going to see a lot of general uptick in full market adoption of these newer, more transparent PBM models.” https://lnkd.in/eXhFUV8a Noah Tong Fierce Healthcare Antonio Ciaccia Jeffrey Townsend Alex Azar Danny S.

Already, large employers are starting to move from traditional PBMs to next-generation upstarts. Convenience store chain 7-Eleven and Purdue University will be moving to AffirmedRx in 2025. “We’re seeing the early adopters move,” Greg Baker, CEO of AffirmedRx told Fierce Healthcare. “In 2025 and 2026, we’re going to see the fast followers move. And in 2026 and 2027, I think we’re really going to see a lot of general uptick in full market adoption of these newer, more transparent PBM models.” https://lnkd.in/eXhFUV8a Noah Tong Fierce Healthcare Antonio Ciaccia Jeffrey Townsend Alex Azar Danny S.

If you want to change the system, you have to become the solution. At AffirmedRx, we made a bold choice: to stop standing on the sidelines and start reshaping the pharmacy benefit management (PBM) industry to truly work for employers and their teams. We’re here to guide benefits leaders like you through the complexities of healthcare, offering a clear path to ethical, transparent and cost-effective solutions. By standing up as a Public Benefit Corporation, we’ve built our entire mission on putting people—not profits—first. Every decision we make is designed to empower you to offer benefits that make a real difference. Greg Baker, CEO, sat down with host Matthew Monahan on The Benefit Summary to talk about what it means to be a trusted partner in pharmacy benefits and how we're bringing change to the industry. 🎥 Watch the whole podcast here: https://lnkd.in/ePNfrbjK #PBMReform #TransparencyInHealthcare #EmployerSolutions #AffirmedRx

"Let’s get to a point where we’re removing conflict from every step of the health care supply chain and then pull value from each of those steps uniquely." This powerful statement from our CEO, Greg Baker, underscores AffirmedRx’s mission to transform the pharmacy benefit industry. Don't miss this insightful discussion with Briana Contreras at Managed Healthcare Executive about rethinking health care and leading with transparency. https://lnkd.in/eSrB4F2H #HealthCareTransparency #PBM #AffirmedRx #Innovation Ann Lewandowski Mark Cuban Shawn Gremminger Transparency-Rx Jake Auchincloss Antonio Ciaccia Bil Schmidtknecht

“A common misnomer is that the biggest guys get the best deals, and while that might be true, they don’t pass those savings onto their clients.” In a recent interview with Briana Contreras at Managed Healthcare Executive, AffirmedRx CEO Greg Baker highlighted a clear approach for redefining the role of the PBM industry with an emphasis on prioritizing transparency and delivering savings that truly benefit clients and their members. Learn more from Greg Baker’s interview:  https://lnkd.in/e_7UmR9G #AffirmedRx #Transparency #PBM #CostSavings #BetterHealthcare Ann Lewandowski Mark Cuban Shawn Gremminger Transparency-Rx Jake Auchincloss Antonio Ciaccia Bil Schmidtknecht

This Wall Street Journal article highlights a critical flaw in our health care system: the enormous disparity in prescription drug prices, driven by a system where middlemen profit while American families and businesses bear the cost.⁣ ⁣ The article revealed staggering examples of drug pricing inconsistencies:⁣ ⁣ -Medicare drugs with prices that range by thousands of dollars depending on the plan and location.⁣ -Generic prostate-cancer drugs that cost $815 in one county but surge to $3,356 in another.⁣ -Seniors forced to dip into retirement savings or find part-time jobs just to afford life-saving medications.⁣ ⁣ This isn’t just an isolated issue affecting public safety nets like Medicare—it’s a broken, profit-driven system that impacts private markets too. Patients are paying more than they should while losing access to some of the care they need.⁣ ⁣ 𝐈𝐭’𝐬 𝐜𝐨𝐬𝐭𝐢𝐧𝐠 𝐮𝐬 𝐢𝐧 𝐦𝐨𝐧𝐞𝐲, 𝐚𝐜𝐜𝐞𝐬𝐬, 𝐚𝐧𝐝 𝐡𝐞𝐚𝐥𝐭𝐡—𝐚𝐧𝐝 𝐢𝐭 𝐬𝐡𝐨𝐮𝐥𝐝𝐧’𝐭 𝐛𝐞 𝐭𝐡𝐢𝐬 𝐰𝐚𝐲.⁣ ⁣ We believe there’s a better approach—one that prioritizes transparency, equitable pricing and patient care over profit margins. It's time to address this systemic dysfunction. Let's move toward a future where healthcare serves the people, not profit-first conglomerates.⁣ ⁣ What changes do you think are most urgently needed? Share your thoughts below. Article link: https://lnkd.in/gwSuKdXk

In 2022, Americans abandoned 94 million prescriptions because they couldn’t afford them. For every $1 increase in a drug’s list price, patients paid $2.09 more out of pocket—while pharmacy benefit managers (PBMs) pocketed larger rebates. Congress needs to take action to stop the three big PBMs, which control 80% of the market, from driving up costs, forcing patients into their own high-priced pharmacies and putting local pharmacies out of business.   The solutions are simple and ready to implement: -Full transparency in PBM pricing and rebate practices. -Delinking PBM compensation from drug prices to remove incentives for higher costs. -Sharing negotiated savings directly with patients at the pharmacy counter The evidence is clear, and bipartisan support for reform exists. Yet Congress has failed to act. Each day of delay costs families, businesses and local communities millions.   With just weeks left in this legislative session, Congress must pass PBM reform now. Patients cannot afford another year of price-gouging and abandoning prescriptions.   Read AffirmedRx’s Greg Baker’s piece published today in The Lane Report and demand Congress take immediate steps to fix this system: https://lnkd.in/ecX2BVu2

In 2022, Americans abandoned 94 million prescriptions because they couldn’t afford them. For every $1 increase in a drug’s list price, patients paid $2.09 more out of pocket—while pharmacy benefit managers (PBMs) pocketed larger rebates. Congress needs to take action to stop the three big PBMs, which control 80% of the market, from driving up costs, forcing patients into their own high-priced pharmacies and putting local pharmacies out of business.   The solutions are simple and ready to implement: -Full transparency in PBM pricing and rebate practices. -Delinking PBM compensation from drug prices to remove incentives for higher costs. -Sharing negotiated savings directly with patients at the pharmacy counter The evidence is clear, and bipartisan support for reform exists. Yet Congress has failed to act. Each day of delay costs families, businesses and local communities millions.   With just weeks left in this legislative session, Congress must pass PBM reform now. Patients cannot afford another year of price-gouging and abandoning prescriptions.   Read AffirmedRx’s Greg Baker’s piece published today in The Lane Report and demand Congress take immediate steps to fix this system: https://lnkd.in/ecX2BVu2